One study linked the anti-obesity effect of GIPR antagonism to leptin sensitivity in the hypothalamus, where genetically or pharmacologically blocking GIPR enhanced the anorexigenic properties of leptin in HFD-fed mice. The gene discussed is LEP; the disease is Obesity.